| Tüüp : |
Ajaleht |
|
| Uurimisrühmad : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
| Autor : |
Ensom MHH, Decarie D, Sheppard I. |
| Pealkiri : |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. |
| Publikatsioon : |
Can J Hosp Pharm ; 60, 3: 184-191. 2007 |
|
| Tõendite tase : |
|
| Füüsikaline stabiilsus : |
|
| Keemiline püsivus : |
|
| Muud meetodid : |
|
| Kommentaarid : |
|
Ingredientide nimekiri
 Lansoprazole
|
 |
 |
 |
 |
150 mg
®=? (Abbott Laboratories) |
|
25°C |
 |
| 91 |
 |
|
|
|
|
|
150 mg
®=? (Abbott Laboratories) |
| NaHCO3 8.4% |
25 ml |
| NaOH |
1N = 1.7 ml |
| OraPlus® / OraSweet® (1:1) |
23.3 ml |
| PH= |
8.4 |
|
25°C |
|
| 91 |
|
|
|
|
|
|
150 mg
®=? (Abbott Laboratories) |
|
4°C |
 |
| 91 |
|
|
|
|
|
|
150 mg
®=? (Abbott Laboratories) |
| NaHCO3 8.4% |
25 ml |
| NaOH |
1N = 1.7 ml |
| OraPlus® / OraSweet® (1:1) |
23.3 ml |
| PH= |
8.4 |
|
4°C |
|
| 91 |
|
|
|
|
|
